Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 2, 2026
Purchase
Shares
2,000
Price
$2.00
Total Value
$4.00K
Shares Held After
627,813
% of Holdings
0.3%

Moderna, Inc. (MRNA)

Klinger Shannon Thyme — Chief Legal Officer
Mar 2, 2026
Sale
Shares
13,885
Price
$52.29
Total Value
$726.05K
Shares Held After
59,689
% of Holdings
18.9%

Atara Biotherapeutics, Inc. (ATRA)

Grant-Huerta Yanina — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
100
Price
$5.08
Total Value
$508.30
Shares Held After
31,750
% of Holdings
0.3%

Atara Biotherapeutics, Inc. (ATRA)

Grant-Huerta Yanina — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
377
Price
$5.08
Total Value
$1.92K
Shares Held After
31,850
% of Holdings
1.2%

Atara Biotherapeutics, Inc. (ATRA)

Grant-Huerta Yanina — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
1,603
Price
$5.08
Total Value
$8.14K
Shares Held After
32,227
% of Holdings
4.7%

Atara Biotherapeutics, Inc. (ATRA)

Grant-Huerta Yanina — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
24
Price
$5.08
Total Value
$121.85
Shares Held After
33,830
% of Holdings
0.1%

Gemini Therapeutics, Inc. (GMTX)

Savage William Jacob — Chief Medical Officer
Mar 2, 2026
Sale
Shares
2,986
Price
$66.41
Total Value
$198.30K
Shares Held After
85,211
% of Holdings
3.4%

Gemini Therapeutics, Inc. (GMTX)

Savage William Jacob — Chief Medical Officer
Mar 2, 2026
Sale
Shares
4,392
Price
$65.52
Total Value
$287.77K
Shares Held After
88,197
% of Holdings
4.7%

uniQure N.V. (QURE)

Kapusta Matthew C — Director
Mar 2, 2026
Sale
Shares
34,437
Price
$9.95
Total Value
$342.65K
Shares Held After
604,639
% of Holdings
5.4%
Mar 2, 2026
Sale
Shares
5,466
Price
$17.92
Total Value
$97.97K
Shares Held After
613,471
% of Holdings
0.9%
Mar 2, 2026
Purchase
Shares
1,000
Price
$22.53
Total Value
$22.53K
Shares Held After
7,397
% of Holdings
13.5%

Xeris Biopharma Holdings, Inc. (XERS)

Hecht Beth — Chief Legal Officer and Corporate Secretary
Mar 2, 2026
Sale
Shares
100
Price
$7.06
Total Value
$706.00
Shares Held After
1,226,507
% of Holdings
0.0%

Xeris Biopharma Holdings, Inc. (XERS)

Hecht Beth — Chief Legal Officer and Corporate Secretary
Mar 2, 2026
Sale
Shares
16,567
Price
$6.24
Total Value
$103.38K
Shares Held After
1,226,607
% of Holdings
1.3%

uniQure N.V. (QURE)

Abi-Saab Walid — Chief Medical Officer
Mar 2, 2026
Sale
Shares
1,660
Price
$9.95
Total Value
$16.52K
Shares Held After
148,777
% of Holdings
1.1%
Mar 2, 2026
Sale
Shares
7,229
Price
$39.66
Total Value
$286.72K
Shares Held After
316,545
% of Holdings
2.2%
Mar 2, 2026
Sale
Shares
42
Price
$203.57
Total Value
$8.55K
Shares Held After
42,720
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
50
Price
$202.54
Total Value
$10.13K
Shares Held After
42,762
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
83
Price
$201.65
Total Value
$16.74K
Shares Held After
42,812
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
41
Price
$200.40
Total Value
$8.22K
Shares Held After
42,895
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
204
Price
$199.69
Total Value
$40.74K
Shares Held After
42,936
% of Holdings
0.5%
Mar 2, 2026
Sale
Shares
47
Price
$197.14
Total Value
$9.27K
Shares Held After
43,140
% of Holdings
0.1%

uniQure N.V. (QURE)

KLEMT CHRISTIAN — Chief Financial Officer
Mar 2, 2026
Sale
Shares
12,532
Price
$9.95
Total Value
$124.69K
Shares Held After
198,981
% of Holdings
5.9%
Mar 2, 2026
Purchase
Shares
17,428
Price
$0.35
Total Value
$6.15K
Shares Held After
5,924,075
% of Holdings
0.3%
Mar 2, 2026
Sale
Shares
39,272
Price
$25.39
Total Value
$997.19K
Shares Held After
22,123
% of Holdings
64.0%
Mar 2, 2026
Sale
Shares
1,442
Price
$5.09
Total Value
$7.34K
Shares Held After
61,978
% of Holdings
2.3%
Mar 2, 2026
Sale
Shares
1,298
Price
$5.09
Total Value
$6.60K
Shares Held After
63,420
% of Holdings
2.0%
Mar 2, 2026
Sale
Shares
58
Price
$5.08
Total Value
$294.64
Shares Held After
64,718
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
198
Price
$5.08
Total Value
$1.01K
Shares Held After
64,776
% of Holdings
0.3%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Liu Joy — EVP and Chief Legal Officer
Mar 2, 2026
Sale
Shares
892
Price
$495.96
Total Value
$442.40K
Shares Held After
22,811
% of Holdings
3.8%

VERACYTE, INC. (VCYT)

Febbo Phillip G. — Chief Scientific & Med Officer
Mar 2, 2026
Sale
Shares
13,425
Price
$36.16
Total Value
$485.43K
Shares Held After
117,346
% of Holdings
10.3%
Mar 2, 2026
Sale
Shares
10,000
Price
$25.65
Total Value
$256.52K
Shares Held After
49,744
% of Holdings
16.7%

Alkermes plc. (ALKS)

Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Mar 2, 2026
Sale
Shares
9,000
Price
$29.72
Total Value
$267.49K
Shares Held After
89,389
% of Holdings
9.1%

Allogene Therapeutics, Inc. (ALLO)

Beneski Benjamin Machinas — SVP, Chief Technical Officer
Mar 2, 2026
Sale
Shares
7,132
Price
$2.60
Total Value
$18.54K
Shares Held After
203,040
% of Holdings
3.4%

Alkermes plc. (ALKS)

Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Mar 2, 2026
Sale
Shares
2,034
Price
$29.29
Total Value
$59.58K
Shares Held After
237,660
% of Holdings
0.8%

Vericel Corp (VCEL)

Halpin Michael — Chief Operating Officer
Mar 2, 2026
Sale
Shares
10,305
Price
$35.30
Total Value
$363.77K
Shares Held After
16,080
% of Holdings
39.1%
Mar 2, 2026
Sale
Shares
5,714
Price
$45.92
Total Value
$262.39K
Shares Held After
61,324
% of Holdings
8.5%
Mar 2, 2026
Sale
Shares
22,223
Price
$44.88
Total Value
$997.37K
Shares Held After
67,038
% of Holdings
24.9%
Mar 2, 2026
Sale
Shares
12,063
Price
$44.20
Total Value
$533.18K
Shares Held After
89,261
% of Holdings
11.9%
Shares
156,235
Price
$8.17
Total Value
$1.28M
Shares Held After
2,704,496
% of Holdings
5.5%

Vericel Corp (VCEL)

Flynn Sean C. — Chief Legal Officer
Mar 2, 2026
Sale
Shares
15,000
Price
$35.36
Total Value
$530.40K
Shares Held After
1,262
% of Holdings
92.2%

Vericel Corp (VCEL)

Flynn Sean C. — Chief Legal Officer
Mar 2, 2026
Sale
Shares
6,421
Price
$34.75
Total Value
$223.13K
Shares Held After
1,262
% of Holdings
83.6%
Mar 2, 2026
Sale
Shares
100
Price
$10.83
Total Value
$1.08K
Shares Held After
21,906
% of Holdings
0.5%

Vanda Pharmaceuticals Inc. (VNDA)

Birznieks Gunther — SVP, Business Development
Mar 2, 2026
Sale
Shares
42,431
Price
$8.27
Total Value
$350.73K
Shares Held After
494,197
% of Holdings
7.9%
Mar 2, 2026
Sale
Shares
6,097
Price
$8.30
Total Value
$50.60K
Shares Held After
89,790
% of Holdings
6.4%
Mar 2, 2026
Sale
Shares
583
Price
$47.01
Total Value
$27.41K
Shares Held After
45,761
% of Holdings
1.3%
Mar 2, 2026
Sale
Shares
1,292
Price
$46.67
Total Value
$60.30K
Shares Held After
46,344
% of Holdings
2.7%
Mar 2, 2026
Sale
Shares
10,429
Price
$47.01
Total Value
$490.31K
Shares Held After
98,748
% of Holdings
9.6%
Mar 2, 2026
Sale
Shares
22,487
Price
$46.67
Total Value
$1.05M
Shares Held After
109,177
% of Holdings
17.1%

Whitehawk Therapeutics, Inc. (WHWK)

Giacobello Scott M. — CHIEF FINANCIAL OFFICER
Mar 2, 2026
Sale
Shares
2,594
Price
$3.31
Total Value
$8.59K
Shares Held After
28,100
% of Holdings
8.5%

Whitehawk Therapeutics, Inc. (WHWK)

BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Mar 2, 2026
Sale
Shares
1,834
Price
$3.31
Total Value
$6.07K
Shares Held After
206,019
% of Holdings
0.9%
Version: v26.3.33